PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportslennox gastaut syndrome
MeSH D065768 - lennox gastaut syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D030342:Inborn genetic diseases
4 Companies
3 Drugs
$
Success rate
D000073376:Epileptic syndromes
1 Company
1 Drug
$
Success rate
D065768: 
Lennox gastaut syndrome
75 Companies
8 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaClobazam Clobazam  2020-01-31   
Topiramate Topiramate  2009-03-27   
Taro PharmaceuticalClobazam Clobazam  2018-10-22   
Glenmark PharmaceuticalsTopiramate Topiramate  2009-03-27   
MylanClobazam Clobazam  2018-10-22   
NATCO PharmaTopiramate Topiramate  2009-03-27   
Johnson & JohnsonTopiramate Topamax  1996-12-24   
CiplaTopiramate Topiramate  2009-03-27   
Lupin ResearchClobazam Clobazam  2018-12-14   
Topiramate Topiramate  2024-07-11   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
100%
3/3
Phase 3
57%
8/14
Approved: 6Overall Success rate: 57%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Lamotrigine,
Topiramate
Mylan
Clonazepam,
Lamotrigine
Johnson & Johnson
Topiramate
GSK
Lamotrigine
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use